Office of Research COVID-19 Extramural Research Funding - Office of Research

COVID-19 Extramural Research Funding

Return to COVID-19 Research Working Group website

COVID-19 research funding opportunities relevant to UC Davis researchers will be added to this table as they are released by federal and state funding agencies, foundations, non-profits and industry partners. Please use the sorting and search tools below to find the opportunities most useful to you. Suggest additional entries by emailing msparling@ucdavis.edu.

The Office of Foundation and Corporate Engagement provides support for your proposals to foundations and corporate sponsors (fce@ucdavis.edu). All proposals for sponsored projects funded by government or non-profit sponsors are reviewed and authorized for submission by the Sponsored Programs Office (SPO). SPO is currently offering an expedited review process for all COVID-19 related proposals. Contact them at proposals@ucdavis.edu.

SponsorSponsor TypeProgram TitleLinkSponsor DeadlinePosted OnFunding Area(s)DescriptionAmount
National Institutes of Health (NIH-NIMH, NIDA)NIHNotice of Special Interest (NOSI): Research on Strategies to Enhance Mental Health Interventions and Services within Employment and Job Training Settingshttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-230.html05/17/2021 is first deadline05/11/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest (NOSI) is to encourage research focused on detection and intervention to prevent or treat mental health concerns, symptoms or disorders including drug-related conditions among unemployed and underemployed people participating in employment programs and job training settings (referred to here as “employment service customers” or “customers”). Considering the COVID-19 pandemic, the sharp rise and potentially long duration of unemployment raises concerns about the development and worsening of mental health symptoms and disorders, drug use behaviors, and suicide risk and necessitates further research to confirm the efficacy or demonstrate effectiveness of strategies in this area.
Health Resources and Services Administration (HRSA)Non-NIH FederalCommunity-Based Workforce for COVID-19 Vaccine Outreachhttps://ucdavis.infoready4.com/#competitionDetail/184280105/10/2021* this is the internal deadline05/06/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.$12,500,000 for six months
Centers for Disease Control (CDC)Non-NIH FederalGlobal Healthcare Detection and Responsehttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33311706/28/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborFighting emerging infections, antibiotic resistance, and delivering essential medical care depends on a safe and functional healthcare system. This Notice of Funding Opportunity (NOFO) will enhance detection and response to emerging infectious disease threats in healthcare facilities through a global collaborative network approach. The purpose of the network is to rapidly detect and actively contain emerging infectious disease threats in healthcare settings by setting targeted priority goals for prevention, including pathogens or conditions, and working collaboratively to achieve these goals through detection and response. These objectives will be met through implementing detection and response services at local, national, and regional levels; evaluating and continually improving implementation; monitoring and assessing impact; conducting implementation science and innovation to inform strategies; enhancing laboratory capacity at key participating labs; and actively facilitating learning to other partners in the country/region.Average Award $800,000 per budget period, over five years
Centers for Disease Control (CDC)Non-NIH FederalEnhancing Innovations and Capabilities of the Environmental Public Health Tracking Network; Approaches to Data Modernizationhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33189506/21/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe Environmental Public Health Tracking Program (Tracking Program) and the Water, Food and Environmental Health Services Branch (WFEHSB) within the Division of Environmental Health Science and Practice share the common goal of modernizing the collection, integration, dissemination, and application of timely, environmental health (EH) data. Current gaps exist in the sharing of standardized EH services data related to inspections, investigations, public inquiries and complaints. These data are routinely generated and collected by EH programs and they include, inspection results and violations, facility closures, permits, or licenses issued, investigation findings, public inquiries, and responses to complaints. These gaps limit both our ability to generate and apply evidence-based practices and interventions and our situational awareness and monitoring capacity at the national level. For example, as communities navigate the current response to COVID-19, EH services data are needed to detect environmental exposure trends by facility type and activities and events licensed and/or monitored by EH programs. These data could be used to assess environmental factors associated with exposure and to develop site specific and community interventions, especially in communities disproportionately affected by COVID-19 (racial and ethnic minority groups, persons meeting HHS poverty guidelines criteria and/or homelessness, low-wage essential workers, and socioeconomic disadvantaged populations in rural and urban areas).Ceiling of Individual Award Range: $ 300,000
Robert Woods Johnson Foundation (RWJF)FoundationResearch in Transforming Health and Health Care Systemshttps://www.rwjf.org/en/library/funding-opportunities/2021/research-in-transforming-health-and-health-care-systems.html?rid=0032S000029g9CQQAY&et_cid=245310606/28/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation EngagementFunding will range from $150,000 to $350,000 per project to accommodate studies of 12 to 36 months.
US Food and Drug Administration (FDA)Non-NIH FederalPediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optionalhttps://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-035.html07/06/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe goal of this program is to support the development of a compendium-type resource incorporating pediatric and perinatal COVID-19 registries, natural history, and other data to support the linkage of mother-infant pair data in COVID-19 positive mothers and to identify the short and longer-term outcomes in neonates and infants who are perinatally exposed to and/or test positive for SARS CoV-2.It is anticipated that up to one award will be made, not to exceed $1,000,000 in total costs (direct plus indirect).
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youthhttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-026.html06/05/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborTreating injured and traumatized children and efforts to implement preventive interventions have become increasingly challenging in the context of the current pandemic. Children are notably at greater risk of injury, morbidity and mortality due to the social isolation, economic stressors, and other challenges related to policies and practices designed to mitigate the spread of the coronavirus. Given the limitations of traditional contexts for identifying and reporting abuse due to these mitigation strategies, research on treatment and care in diverse (e.g. primary, emergency and acute care) settings is essential to identify effective ways of screening, diagnosing and assessing trends in abuse and abuse related injuries in this current context.
Centers for Disease Control (CDC)Non-NIH FederalStrengthening environmental health capacity (EHC) to detect, prevent, and control environmental health hazards through data-driven, evidence-based approaches; pilot EHR/COVID-19 community mitigation * Forecasted *https://www.grants.gov/web/grants/view-opportunity.html?oppId=33308107/23/2021* estimated04/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis project will be initiated through the CDC environmental health capacity (EHC) project Component B and Component C, the purpose of this project is to assess the implementation of COVID-19 community mitigation strategies in communities disproportionately affected by COVID-19. Focus will be on mitigation strategies promoting behaviors that prevent the spread of the virus and maintain healthy environments (e.g., cleaning and disinfection, proper ventilation, safe water systems, etc.). Project objectives include identifying any existing challenges and differences in strategy implementation to prevent COVID-19 transmission and reduce impact among racial and ethnic minority groups, people with lower incomes and/or experiencing poverty or homelessness, low-wage essential workers, and rural communities.$500,000 - $2,300,000
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations - RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-103.html05/24/202104/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) are issuing this NOSI in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This NOSI provides an expedited funding mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines.Individual requests can be no more than $750,000 in direct costs for the entire 2-year budget.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptakehttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-101.html05/10/202104/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborApplications are being requested from current RADx-UP recipientsIndividual requests can be no more than $300,000 in total costs per year for up to one year.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirushttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-041.html03/31/2022 is expiration date04/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19. NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.Application budgets are generally limited to no more than $100,000 direct costs per year. Should the proposed research require a higher budget, the applicant should consult with the program official assigned to the parent award and include a strong justification for the larger budget in the supplement application. The proposed budget must reflect the actual needs of the proposed project.
Department of Health and Human Services (DHHS)Non-NIH FederalForecasted: Vaccine Confidence Collaborationhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33287406/30/2021* estimate04/15/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe Department of Health and Human Services (HHS), Office of Infectious Disease and HIV/AIDS Policy (OIDP) seeks to increase vaccine confidence among adults and children (parents and guardians) across the United States. Vaccines are among the most effective public health interventions available, behind only access to clean water in terms of reducing the burden of infectious diseases. An essential pillar of success for a national vaccine program is maintaining high rates of immunity in communities. To reach the necessary number of vaccinated individuals within a population for community immunity, a high level of public trust in the immunization systems, i.e., vaccine confidence, is needed. The initiative will look to the work of local communities and their partnerships with immunization “champions” to identify, plan, implement, and evaluate evidence-based practices. The funding will focus on improving confidence in three areas: confidence in the project, in the provider, and in policy. OIDP will lead this initiative in partnership with the Office of Regional Health Operations (ORHO), within the Office of the Assistant Secretary for Health (OASH).TBA
National Institutes of Health (NIH)NIHEmergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing Among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-009.html07/07/202104/15/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborHigh rates and disparities of COVID-19 infection, morbidity, and mortality continue among underserved and vulnerable populations across the United States. The overarching goal of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative is to understand and ameliorate factors that have placed a disproportionate burden of the pandemic on underserved and/or vulnerable populations, specifically by implementing programs that expand the scope and reach of COVID-19 testing interventions to reduce these disparities. To address barriers to testing and vaccination, social, ethical, and behavioral research is urgently needed to inform related mitigation efforts. This Phase II RADx-UP Funding Opportunity Announcement (FOA) is designed to expand research to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing interventions among underserved and vulnerable populations. Desirable studies for Phase II will move beyond descriptive health disparities research to focus on developing interventions and other actionable solutions in collaboration with community partners and stakeholders. The funding for this initiative is provided from the American Rescue Plan Act of 2021.Application budgets are limited to $400,000 per year in Direct Costs and need to reflect the actual needs of the proposed project. Up to 2 years.
National Institutes of Health (NIH)NIHEmergency Awards: Community-engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations -- RADx-UP Phase II (U01 Clinical Trial Optional)https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-008.html07/07/202104/15/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the American Rescue Plan Act of 2021 .Application budgets in general are limited to $750,000 per year in Direct Costs and need to reflect the actual needs of the proposed project. Application budget requests over $750,000 in Direct Costs for any year must meet the additional criteria described in Section 1. Up to 2 years.
US Deparment of Health and Human Services (DHHS)Non-NIH FederalCommunity Mental Health Centers Grant Programhttps://www.samhsa.gov/grants/grant-announcements/sm-21-01405/21/202104/13/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS), is accepting applications for fiscal year (FY) 2021 Community Mental Health Centers (Short Title: CMHC) grant program. The purpose of this program is to enable community mental health centers to support and restore the delivery of clinical services that were impacted by the COVID-19 pandemic and effectively address the needs of individuals with serious emotional disturbance (SED), serious mental illness (SMI), and individuals with SMI or SED and substance use disorders, referred to as co-occurring disorder (COD). SAMHSA recognizes the needs of individuals with behavioral health conditions, including minority populations and economically disadvantaged communities, have not been met during the pandemic and that CMHC staff and other caregivers have been impacted.Estimated Award Amount: From $500,000 to $2,500,000 per year for up to 2 years
National Institutes of Health (NIH)NIHEmergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01)https://grants.nih.gov/grants/guide/pa-files/PAR-21-213.html06/09/202104/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this FOA is to advance research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family, and community behavior and on how subsequent economic disruption affects health-related outcomes, with close attention to underserved and vulnerable populations. To address these questions, this FOA aims to form a research consortium to access, extract, integrate, share, and analyze existing data from various sources with broad population coverage including underserved and vulnerable populations. Examples of existing data include public health data; personal digital data; economic, labor, and commerce data; electronic health records (EHRs); claims data; and ongoing health, demographic, and social surveys. This FOA solicits applications for individual population research projects that will be linked to a Social, Behavioral, and Economic Research on COVID-19 Consortium Coordination Center (SBECCC) to foster collaboration and synergies across consortium member projects.Application budgets are limited to less than $500,000 in direct costs in any year. All requested costs need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
National Science Foundation (NSF)Non-NIH FederalTrans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (T-AP RRR)https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=50590907/12/202104/06/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe Trans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (T-AP RRR) opportunity supports international, collaborative research projects that address key gaps in our understanding of the complex societal effects of COVID-19.  Specifically, T-AP RRR supports research that addresses one or more of the following challenges:  reducing inequalities and vulnerabilities; building a more resilient, inclusive, and sustainable society; fostering democratic governance and participation; advancing responsible and inclusive digital innovation; and/or ensuring effective and accurate communication and media.
National Institutes of Health (NIH-NIMH, NICHD)NIHNotice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Childrenhttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-225.html06/05/202104/06/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to understand the mental health impact of the Coronavirus Disease 2019 (COVID-19) pandemic on school-aged children, specifically ages 3 - 12. Particularly, we are interested in the potential impact of primary instruction settings disruptions (e.g., pre-school, elementary school) on the mental health, cognitive, social, and emotional development of children. Empirical data would aid in balancing health risks for various public health mitigation strategies affecting children in the current pandemic as well as inform how to both be prepared and respond to future public health emergencies, including pandemics and disaster scenarios.
US Department of Health and Human Services (DHHS)Non-NIH FederalInnovations in Nutrition Programs and Services - Community Researchhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33235705/24/202103/30/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this funding opportunity is to verify the effectiveness of SNP innovative programs or practices implemented during COVID-19 that positively impact participants. Project goals and outcomes must relate to the OAA SNP intents (specifically: a) reduce hunger, food insecurity and malnutrition, b) promote socialization, and c) promote health and well-being by delaying the onset of adverse health conditions, through the provision of meals and associated nutrition services to vulnerable older adults who are in greatest social and economic need.). Proposed projects must have strong potential for replication by the aging services network and sustainability using OAA Title IIIC-1 funding.Award Ceiling: $ 300,000 Per Budget Period; Award Floor: $ 300,000 Per Budget Period; Length of Project Period: 36-month project period with three 12-month budget periods
National Institutes of Health (NIH-NINDS)NIHNotice of Special Interest (NOSI): Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populationshttps://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-037.html05/05/202103/30/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNINDS is interested in applications for supplements to human subjects awards administered by the NINDS to conduct research on the effects of COVID-19 on the development of, or disease progression in, Alzheimer's Disease-Related Dementias (ADRDs). ADRDs include Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD), Vascular contributions to Cognitive Impairment and Dementia (VCID), and Mixed Etiology Dementias (MED). Older adults are known to be especially vulnerable to COVID-19 infection, and COVID-19 infection commonly presents with neurological signs and symptoms. The effect of COVID-19 exposure on subjects who have, or are at risk for developing ADRDs is unclear. Investigators who are currently researching ADRD or at-risk for ADRD populations are encouraged to apply for additional support to examine the impact of COVID-19 in these subjects.Application budgets must reflect the actual needs of the proposed project. Supplement budget requests may not exceed $666,000 per year in direct costs or 100% of the direct costs of the current year of the parent award (exclusive of Facilities and Administrative costs on sub-contracts), whichever amount is lower.. Applications that want to propose higher budgets must receive permission from the project officer and IC Contact prior to submission.
National Institutes of Health (NIH-NIAID)NIHEnhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated Diseases (U24)https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-021.html07/02/202103/19/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge across the immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on enhancement and/or sustaining operations and improving the user experience and availability of existing, widely adopted informatics tools and resources. This contrasts with exploratory (R21) and early-stage (U01) development efforts to generate these tools and resources that are supported by the companion FOAs.Direct costs are limited to $600,000 per year. The maximum project period is five years.
National Institutes of Health (NIH-NIAID)NIHEarly-Stage Development of Data Science Technologies for Infectious and Immune-Mediated Diseases (U01)https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-020.html07/02/202103/19/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge for immune-mediated and infectious diseases including disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment and vaccines across the allergy, immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications. This contrasts with exploratory (R21) and enhancement/sustainment (U24) efforts to generate these tools and resources that are supported by the companion FOAs.Direct costs are limited to $300,000 per year. The scope of the proposed project should determine the project period. The maximum project period is 3 years.
National Institutes of Health (NIH-NIAID)NIHExploratory Data Science Methods and Algorithm Development in Infectious and Immune-Mediated Diseases (R21)https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-035.html07/02/202103/19/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious or immune-mediated disease research continuum aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID Data Science program, this R21 FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods, including artificial intelligence and machine learning approaches, that can considerably improve acquisition, management, analysis, visualization, and dissemination of relevant data and/or knowledge. This contrasts with early-stage development (U01) and enhancement/sustainment (U24) efforts to generate these tools and resources that are supported by the companion FOAs.The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Office to Monitor and Combat Trafficking in Persons (DOS)Non-NIH Federal2020 Annual Program Statement Full Proposals to Address the Impacts of COVID-19https://www.grants.gov/web/grants/view-opportunity.html?oppId=33213406/30/202103/19/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe 2020 TIP Office Annual Program Statement to Address the Impacts of COVID-19 seeks to combat the rapidly changing impacts of COVID-19 and government measures to counter it on human trafficking.
Health Resources and Services Administration (HRSA)Non-NIH FederalQuality Improvement Solutions for Sustained Epidemic Control Project (QISSEC)https://ucdavis.infoready4.com/#competitionDetail/183853105/07/2021*03/17/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
US Food and Drug Administration (FDA)NIHEnhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01)https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-033.html05/18/202103/15/2021Engineering; Life SciencesThe Center for Biologics Evaluation and Research (CBER) seeks to support several research projects that are focused on developing novel technologies for the advanced manufacturing of complex biologic products or innovative analytical approaches for improving product manufacturing and quality.It is anticipated that up to (4) awards will be made, not to exceed $500,000 in total costs (direct plus indirect), per award, over up to 3 years.
National Institutes of Health (NIH-NIGMS)NIHNotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-019.html12/16/202103/04/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for modeling research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19).
National Institutes of Health (NIH-NIA)NIHNotice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegenerationhttps://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-016.html06/05/202103/04/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest (NOSI) is to inform applicants to the National Institute on Aging (NIA) of NIA’s interest in basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) in aging and age-related neurodegeneration.
Coalition for Epidemic Preparedness Innovations (CEPI)Academic Research InstituteComplementary clinical trials: Expanding access to COVID-19 vaccines and rapid response to clinical development gapshttps://cepi.net/get_involved/cfps/05/28/202102/17/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborCEPI is pleased to announce a new funding opportunity for clinical trials with the aim to rapidly expand access to and confidence in COVID-19 vaccines by i) generating clinical evidence in special / sub-populations / age groups or ii) addressing clinical development gaps. Clinical trials which expand access and capacity in low- and middle-income countries (LMICs) are particularly encouraged.
National Institutes of Health (NIH-NIAID, NIMH)NIHNotice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Researchhttps://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-011.html06/16/202102/16/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis Notice of Special Interest (NOSI) is to support projects that use data, alone or in combination, to address scientific questions and knowledge gaps in basic or clinical research in immune-mediated and infectious diseases.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-017.html05/05/202102/10/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is interested in receiving research applications focusing on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disordershttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-018.html05/07/202102/10/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is interested in receiving research applications focusing on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic.
National Institutes of Health (NIH-NIDCR)NIHNotice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-001.html06/05/202102/02/2021Epidemiology / Public Health; Life SciencesThe National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19).
Centers for Disease Control (CDC)Non-NIH FederalCommunity Health Workers for COVID Response and Resilient Communities (CCR) - Evaluation and Technical Assistance (ETA) (Forecasted)https://www.grants.gov/web/grants/view-opportunity.html?oppId=33105705/22/2021 estimated01/25/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a forecasted opportunity. The call is estimated to be posted on March 23rd.Award range $1M - $3M
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparitieshttps://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-008.html01/08/202201/07/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis Notice of Special Interest (NOSI) highlights the need for research strategies and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the US.* Research is needed to understand and address misinformation, distrust, and hesitancy regarding vaccines (e.g., SARS-CoV-2, pneumococcal, influenza, hepatitis B, human papilloma virus (HPV), and herpes zoster) among adults in the United States and territories, especially in populations at increased risk for morbidity and mortality due to long-standing systemic health and social inequities and chronic medical conditions. The purpose of this NOSI is to solicit community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy.
National Insitutes of Health (NIH-NIMH)NIHNotice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH Researchhttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-120.html06/02/202301/07/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic.
Centers for Disease Control (CDC)Non-NIH FederalCommunity Health Workers for COVID Response and Resilient Communities (CCR)https://www.grants.gov/web/grants/view-opportunity.html?oppId=33054305/24/202101/05/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborForecasted Opportunity! Not yet released call. See link.Estimated award ceiling: $5,000,000
Pfizer Inc.Industry SponsorCOVID-19 General Research Grantshttps://www.pfizer.com/purpose/independent-grants/investigator-sponsored-research12/15/2020 begins rolling deadline12/16/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemichttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html05/08/202311/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: 1) Encourage research to address the rehabilitation needs of survivors of COVID-19; 2) Understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; and 3) Understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
National Institutes of Health (NIH-NIDCD)NIHNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disordershttps://grants.nih.gov/grants/guide/notice-files/NOT-DC-20-008.html09/08/202211/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborCoronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD's scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Projecthttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-129.html07/13/202111/13/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals with Down syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infectionhttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-084.html09/08/202411/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.
National Institutes of Health (NIH-NHLBI)NIHNotice of Special Interest (NOSI): The Influence of Host Resiliance on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-814.html07/06/202411/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice of Special Interest (NOSI) is to inform potential applicants of the special interest of NHLBI in research to understand host resilience as a critical determinant of outcomes in acute respiratory distress syndrome (ARDS) /acute lung injury (ALI).
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Emerging Viral Infections and Their Impact on the Male and Female Reproductive Tracthttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html07/16/202311/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice is to invite applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. The recent global outbreak of the novel coronavirus, SARS-CoV-2, is not an anomaly and will most likely not be the last virus occurrence. Today, infectious diseases are emerging and reemerging more quickly than ever before. In the last four-five years alone, two viral infections, one caused by the Zika virus (ZIKV) and the other caused by a SARS-CoV-2 (Covid19), have spread world-wide, resulting in death, severe disease with yet, unknown, long-term morbidities., or severe birth defects to the new-born. Both ZIKV and SARS-CoV-2 infections may affect male and/or female reproductive systems in addition to other non-reproductive sites. Therefore, it becomes essential to investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific.
National Institutes of Health (NIH-NIAID)NIHNotice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-051.html09/08/202111/09/2020Epidemiology / Public Health; Life Sciences
BARDANon-NIH FederalOperation Warp Speed Broad Agency Announcement OWS-BAA-20-01https://beta.sam.gov/opp/d3b19cfbad31430dab3880812ce2abf3/view?index=opp&preference_id=300d6387-f360-4099-8eee-52a1659952c7&page=11&sort=-modifiedDate&keywords=%22broad%20agency%20announcement%22%20%22BAA%22&date_filter_index=0&inactive_filter_values=fals08/10/2020Epidemiology & Public Health; Life SciencesOperation Ward Speed (OWS) released a broad agency announcement (BAA) to solicit pre-proposals for procurement contracts, other transaction agreements, and technology investment agreements related to Plasma or Therapeutics (based on current announcement). OWS anticipates releasing future calls and solicitations under this BAA.
National Institutes of Health (NIH)NIHUrgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01)https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-20-003.html08/06/2020 begins rolling deadlines08/10/2020Epidemiology / Public Health; Life SciencesThe purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial.Up to $9M over 3 years
Economic Development Administration (EDA)Non-NIH FederalPublic Works and Economic Adjustment Assistance Programs including CARES Act Fundinghttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32169508/04/2020Community & Social Services; Policy, Economics & LaborCARES Act Recovery Assistance Projects: Successful applications will enable affected communities to respond to the impacts of the coronavirus pandemic by supporting affected businesses and communities, including by providing technical assistance to retain existing and hire new employees; by providing a range of skills-training and workforce development projects to help employees compete for high-quality jobs; and by developing and implementing strategies to diversify regional economies to create jobs in new or existing industries.Range from $150,000 to $1,000,000
Emergent VenturesAcademic Research InstituteSECOND ROUND: Emergent Ventures Fast Funding for COVID-19 Sciencehttps://fastgrants.org/07/21/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Humanities; Life Sciences; Policy, Economics, and LaborIf you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, the Emergent Ventures project at the Mercatus Center invites you to apply for a Fast Grant. A Fast Grant must be used solely to expedite COVID-19-related science, but the area of research is open. Fast grants are $10k to $500k and decisions are made in under 14 days.Up to $500,000
CiscoIndustry SponsorPandemic/COVID19 Science, Technology and Social Impacthttps://research.cisco.com/research#rfp-20200407/16/2020Data Science, AI & Computing; Engineering; Epidemiology & Public HealthFor more information about this opportunity, please contact Scott Stevenson (swstevenson@ucdavis.edu), Associate Director of Corporate EngagementNo limitations
National Institutes of Health (NIH - NIAID)NIHLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10)https://grants.nih.gov/grants/guide/pa-files/PAR-20-256.html07/13/2020 begins rolling deadline07/15/2020Community & Social Services; Epidemiology & Public Health; Life SciencesThe purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act”.It is expected that applicants will employ the most economical approaches, including securing academic discounts, to formulate a cost-effective budget while meeting users' needs.
National Institutes of Health (NIH - NIAID)NIHNotice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-059.html07/01/202107/13/2020Epidemiology & Public Health; Life SciencesNIAID is issuing this Notice of Special Interest (NOSI) to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice.
Open Road AllianceFoundationCharitable Grantshttps://openroadalliance.org/covid-19/06/26/2020Community & Social Services; Data Science, AI & Computing; Engineering; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Draper Richards Kaplan FoundationFoundationCOVID-19 Urgent Response Initiativehttps://drive.google.com/file/d/1Dcj2zuFKE72caEBYz5ADOLDWeci802cD/view05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Engineering; Humanities; Policy, Economics & Labor; InstructionDRK is ready to find, fund, and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now. We want to help jumpstart projects that can realistically deploy within 30 days. We are best positioned to help work on the social problems caused by the pandemic versus direct mitigation via medical and scientific efforts. We will filter potential investments through the lens of urgency: Can this make large impact at scale? Can it be deployed quickly? And can DRK be catalytic in making that happen?Anticipated Range $50K-$100K
CETF and Rockefeller Philanthropy AdvisorsFoundationCOVID-19 Early Treatment Fund (CETF)http://www.treatearly.org/apply-for-funding05/12/2020Epidemiology & Public Health; Life SciencesFor more information about this opportunity, please contact Charlie Lemcke (cwlemcke@ucdavis.edu), Assistant Director of Corporate EngagementUp to $1M
Economic Development Administration (EDA)Non-NIH FederalEDA CARES Act Recovery Assistancehttps://www.eda.gov/coronavirus/05/12/2020Community & Social Services; Policy, Economics & LaborThe Coronavirus Aid, Relief, and Economic Security (CARES) Act provides the EDA with $1.5 billion for economic development assistance programs to help communities prevent, prepare for, and respond to coronavirus. EDA CARES Act Recovery Assistance provides a wide-range of financial assistance to communities and regions as they respond to and recover from the impacts of the pandemic. This includes: 1) Planning and Technical Assistance, 2) Construction of Infrastructure and Other Economic Development Projects, 3) Innovation Grants, and 4) Capitalization and Recapitalization of Revolving Loan Funds. Check that the proposed project fits the scope with the EDA regional office; applications reviewed on rolling basis.Typically up to $1,000,000
National Institutes of Health (NIBIB)NIHRapid Acceleration of Diagnostics (RADx)https://www.poctrn.org/radx04/28/2020 begins rolling deadline04/29/2020Epidemiology / Public Health; Life SciencesThe National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.Varies by Phase
National Institutes of Health (NIH)NIHAll open COVID-19 calls and Notices of Special Interest (NOSIs) from the Instituteshttps://grants.nih.gov/policy/natural-disasters/corona-virus.htm04/24/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and Labor; Education and TrainingThis page on the NIH website contains a table of all open COVID-19 calls and Notices of Special Interest (NOSIs) from the Institutes, in addition to other useful information. At this time there are too many NIH NOSIs to add to this table.Various
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)University of CaliforniaCOVID Catalyst Fundinghttp://cend.globalhealth.berkeley.edu/covid-catalyst-rapid-funding-accelerate-covid-19-research/04/20/2020Epidemiology / Public Health; Life SciencesThe Covid Catalyst fund will provide catalytic seed funding for high-risk projects, as well as catalytic bridge funding for lower risk projects that likely will be successful in attracting government funding long-term. We will be able to fund projects for 3-6 months at a time or until a major milestone is reached. High-risk ideas that turn out to be not feasible should be allowed to fail rapidly so that another approach can be taken. Once the milestone is reached, repeat funding is possible to continue towards implementation.Up to $100,000
National Institutes of Health (NIH)NIHEmergency Competitive Revision to Existing NIH Awardshttps://grants.nih.gov/grants/guide/pa-files/PA-20-135.html04/10/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC will be allowed to apply to this FOA.
GoogleIndustry SponsorGoogle Cloud research creditshttps://edu.google.com/programs/credits/research/?modal_active=none04/09/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Amy Skehan (arskehan@ucdavis.edu), Assistant Vice Chancellor of Foundation and Corporate Engagement
BARDANon-NIH FederalCoronaWatch/TechWatch Medical Countermeasureshttps://www.medicalcountermeasures.gov/request-barda-techwatch-meeting/04/07/2020Engineering; Life SciencesTo enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed its existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners. BARDA is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
California Institute for Regenerative Medicine (CIRM)State of CaliforniaCIRM Rapid Research Fundshttps://www.cirm.ca.gov/about-cirm/newsroom/press-releases/03272020/stem-cell-agency-board-approves-5-million-emergency04/07/2020Epidemiology / Public Health; Life SciencesCIRM is issuing this special announcement to support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.Varies by Project Stage
DoD-Joint Acquisition Task Force (JATF)Non-NIH FederalCOVID-19 Request for Information (RFI)https://www.afwerx.af.mil/coronavirus.html04/07/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborDoD JATF is seeking input to shape its COVID-19 funding decisions focused on the accelerated ramp-up of production capacity for critical healthcare products such as masks, ventilators, test kits, and vaccines. JATF Focus Areas: 1) Combating Spread, 2) Welfare of Citizens, 3) Readiness, 4) Logistics, 5) Industrial base impacts, 6) Medical, 7) Other
PfizerIndustry SponsorCompetitive Grants Programhttps://www.pfizer.com/purpose/independent-grants/competitive-grants04/07/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
Allen Institute for AIPublic-Private PartnershipCOVID-19 Open Research Dataset Challengehttps://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge04/02/2020Data Science, AI, ComputingFor more information about this opportunity, please contact Robyn Ireland (rmbireland@ucdavis.edu), Assistant Director of Corporate Engagement$1,000 per task
DoE OSTP IBMPublic-Private PartnershipCOVID-19 High Performance Computing Consortiumhttps://covid19-hpc-consortium.org/04/02/2020Behavior and Psychology; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesThe COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus.  Researchers seeking to access the Consortium’s resources should submit a simple project proposal that will be reviewed for potential impact, computational feasibility, overall resource requirements and timeline.
Gates Foundation, Wellcome Trust, Mastercard, & CZIFoundationCOVID-19 Therapeutics Acceleratorhttps://www.therapeuticsaccelerator.org/04/02/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Ginkgo BioworksIndustry SponsorFree Access to Ginkgo Platformhttps://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/04/02/2020Data Science, AI, Computing; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
NIH-NIAID & NIANIHInvestigator Initiated Extended Clinical Trial (R01)https://grants.nih.gov/grants/guide/pa-files/PAR-20-139.html05/13/2021 next deadline03/30/2020Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.